
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Cardiac function surveillance practices and outcomes in patients with HER2-positive breast cancer treated with trastuzumab: a retrospective cohort study across a safety-net and tertiary care setting - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE532F8F8AF23053052F8F0043B6BF39.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="cardioon">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369133/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Cardio-oncology">
<meta name="citation_title" content="Cardiac function surveillance practices and outcomes in patients with HER2-positive breast cancer treated with trastuzumab: a retrospective cohort study across a safety-net and tertiary care setting">
<meta name="citation_author" content="Le Huang">
<meta name="citation_author_institution" content="Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX USA">
<meta name="citation_author" content="Pratyusha Manthena">
<meta name="citation_author_institution" content="Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX USA">
<meta name="citation_author" content="Malcolm Su">
<meta name="citation_author_institution" content="Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX USA">
<meta name="citation_author" content="Alvin Chandra">
<meta name="citation_author_institution" content="Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX USA">
<meta name="citation_author_institution" content="Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX USA">
<meta name="citation_author_institution" content="Harold C. Simmons Comprehensive Cancer Center, 5323 Harry Hines Blvd, Dallas, TX 75390 USA">
<meta name="citation_author" content="Navid Sadeghi">
<meta name="citation_author_institution" content="Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX USA">
<meta name="citation_author_institution" content="Harold C. Simmons Comprehensive Cancer Center, 5323 Harry Hines Blvd, Dallas, TX 75390 USA">
<meta name="citation_author_institution" content="Parkland Health, Dallas, TX USA">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="11">
<meta name="citation_firstpage" content="74">
<meta name="citation_doi" content="10.1186/s40959-025-00376-9">
<meta name="citation_pmid" content="40842038">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369133/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369133/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369133/pdf/40959_2025_Article_376.pdf">
<meta name="description" content="Anti-HER2 receptor monoclonal antibodies like trastuzumab are the mainstay of treatment in HER2-positive breast cancer but can result in cancer therapy-related cardiac dysfunction (CTRCD). Guidelines recommend cardiac surveillance prior to anti-HER2 ...">
<meta name="og:title" content="Cardiac function surveillance practices and outcomes in patients with HER2-positive breast cancer treated with trastuzumab: a retrospective cohort study across a safety-net and tertiary care setting">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Anti-HER2 receptor monoclonal antibodies like trastuzumab are the mainstay of treatment in HER2-positive breast cancer but can result in cancer therapy-related cardiac dysfunction (CTRCD). Guidelines recommend cardiac surveillance prior to anti-HER2 ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369133/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12369133">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s40959-025-00376-9"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/40959_2025_Article_376.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12369133%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12369133/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12369133/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369133/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-cardioon.png" alt="Cardio-oncology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Cardio-oncology" title="Link to Cardio-oncology" shape="default" href="https://cardiooncologyjournal.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Cardiooncology</button></div>. 2025 Aug 21;11:74. doi: <a href="https://doi.org/10.1186/s40959-025-00376-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s40959-025-00376-9</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Cardiooncology%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cardiooncology%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Cardiooncology%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Cardiooncology%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Cardiac function surveillance practices and outcomes in patients with HER2-positive breast cancer treated with trastuzumab: a retrospective cohort study across a safety-net and tertiary care setting</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Le Huang</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Le Huang</span></h3>
<div class="p">
<sup>1</sup>Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Le Huang</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Manthena%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Pratyusha Manthena</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Pratyusha Manthena</span></h3>
<div class="p">
<sup>1</sup>Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Manthena%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Pratyusha Manthena</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Su%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Malcolm Su</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Malcolm Su</span></h3>
<div class="p">
<sup>1</sup>Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Su%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Malcolm Su</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chandra%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Alvin Chandra</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Alvin Chandra</span></h3>
<div class="p">
<sup>1</sup>Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX USA </div>
<div class="p">
<sup>2</sup>Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX USA </div>
<div class="p">
<sup>3</sup>Harold C. Simmons Comprehensive Cancer Center, 5323 Harry Hines Blvd, Dallas, TX 75390 USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chandra%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alvin Chandra</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sadeghi%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Navid Sadeghi</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Navid Sadeghi</span></h3>
<div class="p">
<sup>1</sup>Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX USA </div>
<div class="p">
<sup>3</sup>Harold C. Simmons Comprehensive Cancer Center, 5323 Harry Hines Blvd, Dallas, TX 75390 USA </div>
<div class="p">
<sup>4</sup>Parkland Health, Dallas, TX USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sadeghi%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Navid Sadeghi</span></a>
</div>
</div>
<sup>1,</sup><sup>3,</sup><sup>4,</sup><sup>✉,</sup><sup>#</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX USA </div>
<div id="Aff2">
<sup>2</sup>Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX USA </div>
<div id="Aff3">
<sup>3</sup>Harold C. Simmons Comprehensive Cancer Center, 5323 Harry Hines Blvd, Dallas, TX 75390 USA </div>
<div id="Aff4">
<sup>4</sup>Parkland Health, Dallas, TX USA </div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Jun 21; Accepted 2025 Aug 6; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12369133  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40842038/" class="usa-link">40842038</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p id="Par1">Anti-HER2 receptor monoclonal antibodies like trastuzumab are the mainstay of treatment in HER2-positive breast cancer but can result in cancer therapy-related cardiac dysfunction (CTRCD). Guidelines recommend cardiac surveillance prior to anti-HER2 therapy initiation, every 3 months during therapy, and within 1 year after therapy completion. Resource limitations in safety-net settings without cardio-oncology programs may impact cardiac surveillance and treatment patterns and contribute to disparities in cardiovascular health among patients with cancer. We aimed to characterize and compare patterns of cardiac surveillance and short-term cardiovascular outcomes among patients with breast cancer receiving trastuzumab in a safety-net versus a tertiary care system.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p id="Par2">A retrospective cohort study was conducted on women diagnosed with stage I-III HER2-positive breast cancer between 2018 and 2020 in a safety-net and a tertiary care system. Clinical data from transthoracic echocardiograms, multigated acquisition scans, and cardiac magnetic resonance imaging one year out from trastuzumab initiation were collected. CTRCD was defined by decrements in left ventricular ejection fraction, global longitudinal strain changes, and symptoms of heart failure. Demographics and referral patterns were also assessed.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p id="Par3">A total of 235 patients were included (93 safety-net, 142 tertiary care). The safety-net population was 23% Black, 60% Hispanic, and 69% uninsured, while the tertiary care population was 64% White and 3.5% uninsured (<em>p</em> &lt; 0.001). Baseline cardiac surveillance was obtained in 84% of safety-net patients and 89% of tertiary care patients, with mean surveillance interval of approximately 3 months. Only 54% of patients at each site obtained cardiac surveillance post-trastuzumab. CTRCD occurred in 12% of patients in the safety-net system and 19% in the tertiary care system, with most cases being asymptomatic (<em>p</em> = 0.143). High-risk patients were more likely to be referred to cardiology/cardio-oncology in the tertiary care system compared to the safety-net system (67% vs. 6.7%, <em>p</em> &lt; 0.001).</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusions</h3>
<p id="Par4">While our data shows similar frequency of cardiac surveillance based on left ventricular ejection fraction at our safety-net and tertiary care center, the utilization of various imaging modalities and cardiology/cardio-oncology services were significantly different between the two institutions. These differences may result in underdiagnosis of CTRCD in vulnerable populations and contribute to inferior long-term cardiovascular outcomes.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Cardio-oncology, Trastuzumab, HER2 therapy, Cardiotoxicity, Health disparities, Cancer therapy-related cardiac dysfunction</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Background</h2>
<p id="Par5">Breast cancer remains one of the leading causes of death for women globally, and human epidermal growth factor receptor-2 (HER2) positive breast cancer accounts for more than 15% of all breast cancers [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. There have been various advancements in the treatment of breast cancer which have improved overall survival. Particularly, targeted treatments directed towards the HER2 receptor with monoclonal antibodies have become a cornerstone in the treatment of both early and advanced breast cancer [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. For instance, patients with early-stage HER2-positive breast cancer routinely are treated with one year of trastuzumab as part of standard care [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. In patients with advanced disease, HER2-directed therapies are continued until the progression of disease, significant toxicities, or death [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>].</p>
<p id="Par6">Though such developments in treatment have conferred improved survival outcomes, patients receiving anti-HER2 medications, such as trastuzumab, have increased risk of development of cancer therapy-related cardiac dysfunction (CTRCD), which often involves a reduction in left ventricular ejection fraction (LVEF) but can also encompass a wide spectrum of cardiac dysfunction characterized by changes in global longitudinal strain (GLS), cardiac biomarkers, and clinical symptoms of heart failure [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Based on the 2022 European Society of Cardiology (ESC) guidelines on cardio-oncology, CTRCD can range from severe symptomatic cases of clinical heart failure requiring inpatient management to asymptomatic cases defined by various thresholds of LVEF and GLS decline [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>].</p>
<p id="Par7">Due to the need to screen for signs of cardiotoxicity during anti-HER2 therapy, there are various guideline recommendations regarding surveillance of cardiac function during therapy, often with echocardiogram but also other modalities like multigated acquisition (MUGA) scans or cardiac magnetic resonance imaging (MRI) [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. For instance, the ESC guidelines have a Class I recommendation to obtain echocardiography at baseline prior to anti-HER2 therapy initiation, every 3 months during therapy, and within 1 year after completion of therapy [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>], while the American Society of Clinical Oncology does not specify a particular interval to conduct routine surveillance during therapy [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. The Food and Drug Administration label for trastuzumab also recommends LVEF assessment at baseline, every 3 months during treatment, and every 6 months for at least 2 years after completion of therapy [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>].</p>
<p id="Par8">With guidelines calling for up to quarterly assessments of cardiac function, initiation of anti-HER2 agents requires patients to have frequent and timely care [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. Limited resources in safety-net settings may impact the timely access to cardiac imaging and impede regular cardiac surveillance. Prior studies have also shown that various sociodemographic factors and health determinants, such as race, may increase the risk of cardiotoxicity in patients treated with anti-HER2 therapy [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. As these same health determinants may place patients at higher risk for other cardiovascular risk factors, such as hypertension and diabetes, it becomes imperative to identify any barriers to timely, guideline-directed care in this patient population. Developing cardio-oncology programs have been suggested as a strategy to improve surveillance, risk mitigation, and treatment of cardiovascular toxicities of cancer care [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. As such, we sought to characterize patterns of cardiac function surveillance in patients who received anti-HER2 therapy in a safety-net hospital system and comprehensive cancer center.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Methods</h2>
<p id="Par9">A retrospective cohort study was conducted to evaluate all newly diagnosed women with stage I-III HER2-positive invasive breast cancer between 2018 and 2020 and treated with trastuzumab at Parkland Health and University of Texas Southwestern (UTSW) Simmons Comprehensive Cancer Center. Parkland Health is the safety-net system for Dallas County and affiliated with UTSW. Patients who were diagnosed with metastatic disease and treated with trastuzumab were excluded from the study given the lack of standardized anti-HER2 therapy duration. Information regarding trastuzumab initiation and completion dates and demographic and clinical data were extracted from review of the electronic medical record by three independent reviewers. Sociodemographic information, including race, insurance status, and ZIP code information, was gathered.</p>
<p id="Par10">The imaging modalities for cardiac function assessment included in this study were transthoracic echocardiography (TTE), MUGA scans, and cardiac MRI. The time frame for included images was limited to 13 months after trastuzumab initiation to reflect the standard 12-month treatment duration of trastuzumab with some flexibility to account for minor delays. A baseline assessment of cardiac function, defined as obtained prior to and closest to trastuzumab initiation, was also included for each patient if one existed. Assessments of cardiac function that were obtained at more frequent intervals than 3 months for any purpose other than cardiotoxic surveillance (e.g. for monitoring pericardial effusion) were excluded. All measurements of LVEF and GLS were recorded and analyzed independently. For those patients who had more than one LVEF assessment and GLS assessment, nadirs of LVEF and GLS were determined, respectively. Additional chart review was done to determine whether a post-trastuzumab assessment of cardiac function was performed within one year of completing trastuzumab therapy, even if this fell outside the 13-month window. However, only data from images obtained within the 13-month window were used in the analysis.</p>
<p id="Par11">Risk stratification was performed for all patients according to a scheme adapted from the Heart Failure Association-International Cardio-Oncology Society (HFA-ICOS) risk stratification scheme proposed in the ESC guidelines [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. We defined high-risk as having any one of the following characteristics: history of heart failure or cardiomyopathy, baseline LVEF 54% or less, age of diagnosis 65 years or older, history of both hypertension and diabetes mellitus, and having received prior anthracyclines. Data on referrals to cardio-oncology/cardiology were also gathered, including the referring provider’s specialty and whether patients successfully initiated care with the cardio-oncology/cardiology service.</p>
<p id="Par12">Categorical data was summarized with counts and percentages and compared with Chi-squared and Fischer exact tests. Continuous variables were summarized with means and standard deviations and compared with paired Student’s T-tests. All statistical analyses were performed using R (version 4.4.2) [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. This research was approved by the local Institutional Review Board and the investigators do not have any conflicts of interest to disclose.</p></section><section id="Sec3"><h2 class="pmc_sec_title">Results</h2>
<p id="Par13">Our cohort included 235 patients diagnosed with breast cancer with a mean (standard deviation) age at diagnosis of 52 (11) years. Ninety-three (40%) patients received their care at Parkland Health and 142 (60%) received their care at UTSW Simmons Comprehensive Cancer Center. The majority of patients at Parkland were Black or Hispanic (83%), while 64% of UTSW patients were White (<em>p</em> &lt; 0.001). At Parkland, 64 (69%) patients did not have insurance at the time of cancer diagnosis, 20 (22%) had Medicare or Medicaid, and 9 (9.7%) had private insurance, while at UTSW, 5 (3.5%) did not have insurance, 33 (23%) had Medicare or Medicaid, 103 (73%) had private insurance (<em>p</em> &lt; 0.001), and one patient had insurance of unknown type.</p>
<p id="Par14">While diabetes was more common among Parkland patients compared to UTSW (27% vs. 15%, <em>p</em> = 0.0328), incidence of dyslipidemia (54% vs. 44%) and hypertension (46% vs. 38%) were similar between the two groups. Seventeen (18%) patients at Parkland and 27 (19%) patients at UTSW were on cardioprotective agents (including beta blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, sodium-glucose cotransporter 2 inhibitors, or mineralocorticoid receptor antagonists) prior to trastuzumab initiation.</p>
<p id="Par15">Mean (standard deviation) duration of trastuzumab therapy was 361 (127) days and 358 (159) days at Parkland and UTSW, respectively. Seventy-eight (84%) and 101 (71%) patients at Parkland and UTSW, respectively, received pertuzumab in addition to trastuzumab (<em>p</em> = 0.025). Five (5.4%) and 16 (11%) patients at Parkland and UTSW, respectively, received anthracyclines prior to trastuzumab therapy.</p>
<p id="Par16">Mean (standard deviation) number of LVEF assessments was 4.4 (SD 1.1) and 4.2 (SD 1.3) at Parkland and UTSW, respectively. Baseline LVEF assessment was obtained in 78 (84%) and 126 (89%) patients at Parkland and UTSW, respectively. Providers at Parkland utilized MUGA scans significantly more, with 34% of all LVEF assessment performed with MUGA scan, 66% with TTE, and none with cardiac MRI. In contrast, providers at UTSW utilized TTE for over 99% of LVEF assessments and MUGA scans and cardiac MRI for less than 1% of LVEF assessments (<em>p</em> &lt; 0.001 between sites). Mean time between LVEF assessments were 99 (SD 23) and 97 (SD 22) days at Parkland and UTSW, respectively. Post-trastuzumab LVEF assessment was obtained in 50 (54%) and 76 (54%) patients at Parkland and UTSW, respectively.</p>
<p id="Par17">Mean baseline LVEF was 62% (SD 5.8%) and 61% (SD 4.9%) at Parkland and UTSW, respectively. Mean nadir LVEF was 56% (SD 4.6%) and 56% (SD 5.0%) at Parkland and UTSW, respectively. Mean change in LVEF from baseline to nadir was − 5.7% (SD 5.2%) at both Parkland and UTSW. Mean baseline GLS was − 20% (SD 2.7%) and − 19% (SD 2.2%) at Parkland and UTSW, respectively (<em>p</em> = 0.0007). Mean nadir GLS was − 18% (SD 2.5%) and − 17% (SD 1.8%) at Parkland and UTSW, respectively (<em>p</em> = 0.0001). Mean change in GLS from baseline to nadir was + 1.4% (SD 1.8%) and + 1.4% (SD 1.6%) at Parkland and UTSW, respectively. Figure <a href="#Fig1" class="usa-link">1</a> summarizes baseline, nadir, and final LVEF and GLS for all patients who had more than one LVEF or GLS assessment.</p>
<figure class="fig xbox font-sm" id="Fig1"><h3 class="obj_head">Fig. 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369133_40959_2025_376_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85bf/12369133/133c49a28a11/40959_2025_376_Fig1_HTML.jpg" loading="lazy" id="d33e371" height="732" width="669" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Left ventricular ejection fraction (<strong>A1</strong>, <strong>B1</strong>) and global longitudinal strain changes (<strong>A2</strong>, <strong>B2</strong>) by hospital system (Parkland: <strong>A</strong>, UTSW: <strong>B</strong>). Dark lines represent the mean. Error bars represent one standard deviation from the mean</p></figcaption></figure><p id="Par19">Similar rates of CTRCD occurred at the two sites. Eleven (12%) Parkland patients and 27 (19%) UTSW patients developed CTRCD with most of these patients developing mild asymptomatic CTRCD (8 at Parkland and 17 at UTSW). Of the entire cohort, only one Parkland patient developed CTRCD with overt heart failure symptoms. At Parkland, of the 11 patients who developed CTRCD, all patients had an LVEF that was 50% or greater at the end of the 13-month follow-up period. At UTSW, of the 27 patients who developed CTRCD, 23 (85%) had an LVEF that was 50% or greater at the end of the 13-month follow-up period. Tables <a href="#Tab1" class="usa-link">1</a>, <a href="#Tab2" class="usa-link">2</a> and <a href="#Tab3" class="usa-link">3</a> provide a summary of patient characteristics, cardiac function surveillance practices, and CTRCD incidence stratified by health system for the overall cohort, while Table <a href="#Tab4" class="usa-link">4</a> presents corresponding data for the subgroup of patients who developed CTRCD.</p>
<section class="tw xbox font-sm" id="Tab1"><h3 class="obj_head">Table 1.</h3>
<div class="caption p"><p>Cohort characteristics by health system</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1"></th>
<th align="left" colspan="1" rowspan="1">Parkland</th>
<th align="left" colspan="1" rowspan="1">UTSW</th>
<th align="left" colspan="1" rowspan="1">Total</th>
<th align="left" colspan="1" rowspan="1"></th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">
<em>n</em> = 93</th>
<th align="left" colspan="1" rowspan="1">
<em>n</em> = 142</th>
<th align="left" colspan="1" rowspan="1">
<em>n</em> = 235</th>
<th align="left" colspan="1" rowspan="1">
<em>p</em>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Age, years, mean (SD)</td>
<td align="left" colspan="1" rowspan="1">50 (9.6)</td>
<td align="left" colspan="1" rowspan="1">53 (12)</td>
<td align="left" colspan="1" rowspan="1">52 (11)</td>
<td align="left" colspan="1" rowspan="1">0.040</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Race</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> White</td>
<td align="left" colspan="1" rowspan="1">9 (9.7%)</td>
<td align="left" colspan="1" rowspan="1">91 (64%)</td>
<td align="left" colspan="1" rowspan="1">100 (43%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Black</td>
<td align="left" colspan="1" rowspan="1">21 (23%)</td>
<td align="left" colspan="1" rowspan="1">21 (15%)</td>
<td align="left" colspan="1" rowspan="1">42 (18%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Hispanic</td>
<td align="left" colspan="1" rowspan="1">56 (60%)</td>
<td align="left" colspan="1" rowspan="1">10 (7.0%)</td>
<td align="left" colspan="1" rowspan="1">66 (28%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Other</td>
<td align="left" colspan="1" rowspan="1">7 (7.5%)</td>
<td align="left" colspan="1" rowspan="1">20 (14%)</td>
<td align="left" colspan="1" rowspan="1">27 (11%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Insurance</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Private</td>
<td align="left" colspan="1" rowspan="1">9 (9.7%)</td>
<td align="left" colspan="1" rowspan="1">103 (73%)</td>
<td align="left" colspan="1" rowspan="1">112 (48%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Medicare/Medicaid</td>
<td align="left" colspan="1" rowspan="1">20 (22%)</td>
<td align="left" colspan="1" rowspan="1">33 (23%)</td>
<td align="left" colspan="1" rowspan="1">53 (23%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No Insurance</td>
<td align="left" colspan="1" rowspan="1">64 (69%)</td>
<td align="left" colspan="1" rowspan="1">5 (3.5%)</td>
<td align="left" colspan="1" rowspan="1">69 (29%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">History of dyslipidemia</td>
<td align="left" colspan="1" rowspan="1">50 (54%)</td>
<td align="left" colspan="1" rowspan="1">63 (44%)</td>
<td align="left" colspan="1" rowspan="1">113 (48%)</td>
<td align="left" colspan="1" rowspan="1">0.159</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">History of diabetes mellitus</td>
<td align="left" colspan="1" rowspan="1">25 (27%)</td>
<td align="left" colspan="1" rowspan="1">22 (15%)</td>
<td align="left" colspan="1" rowspan="1">47 (20%)</td>
<td align="left" colspan="1" rowspan="1">0.0328</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">History of hypertension</td>
<td align="left" colspan="1" rowspan="1">43 (46%)</td>
<td align="left" colspan="1" rowspan="1">54 (38%)</td>
<td align="left" colspan="1" rowspan="1">97 (41%)</td>
<td align="left" colspan="1" rowspan="1">0.211</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Number of cardiovascular risk factors*</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">0.1185</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> None</td>
<td align="left" colspan="1" rowspan="1">26 (28%)</td>
<td align="left" colspan="1" rowspan="1">56 (39%)</td>
<td align="left" colspan="1" rowspan="1">82 (35%)</td>
<td align="left" colspan="1" rowspan="1">0.0928</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> One</td>
<td align="left" colspan="1" rowspan="1">32 (34%)</td>
<td align="left" colspan="1" rowspan="1">45 (32%)</td>
<td align="left" colspan="1" rowspan="1">77 (33%)</td>
<td align="left" colspan="1" rowspan="1">0.6724</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Two</td>
<td align="left" colspan="1" rowspan="1">19 (20%)</td>
<td align="left" colspan="1" rowspan="1">29 (20%)</td>
<td align="left" colspan="1" rowspan="1">48 (20%)</td>
<td align="left" colspan="1" rowspan="1">1.00</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Three</td>
<td align="left" colspan="1" rowspan="1">16 (17%)</td>
<td align="left" colspan="1" rowspan="1">12 (8.5%)</td>
<td align="left" colspan="1" rowspan="1">28 (12%)</td>
<td align="left" colspan="1" rowspan="1">0.0624</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">On prior cardioprotective agents (BB, ACEI/ARB, SLGT2i, MRA)</td>
<td align="left" colspan="1" rowspan="1">17 (18%)</td>
<td align="left" colspan="1" rowspan="1">27 (19%)</td>
<td align="left" colspan="1" rowspan="1">44 (19%)</td>
<td align="left" colspan="1" rowspan="1">1.00</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Trastuzumab duration, days, mean (SD)</td>
<td align="left" colspan="1" rowspan="1">361 (127)</td>
<td align="left" colspan="1" rowspan="1">358 (159)</td>
<td align="left" colspan="1" rowspan="1">361 (146)</td>
<td align="left" colspan="1" rowspan="1">0.960</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Treatment with pertuzumab</td>
<td align="left" colspan="1" rowspan="1">78 (84%)</td>
<td align="left" colspan="1" rowspan="1">101 (71%)</td>
<td align="left" colspan="1" rowspan="1">179 (76%)</td>
<td align="left" colspan="1" rowspan="1">0.025</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Treatment with anthracycline</td>
<td align="left" colspan="1" rowspan="1">5 (5.4%)</td>
<td align="left" colspan="1" rowspan="1">16 (11%)</td>
<td align="left" colspan="1" rowspan="1">21 (8.9%)</td>
<td align="left" colspan="1" rowspan="1">0.122</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p23"><p>*Cardiovascular risk factor defined as hypertension, hyperlipidemia, or diabetes mellitus</p></div></div></section><section class="tw xbox font-sm" id="Tab2"><h3 class="obj_head">Table 2.</h3>
<div class="caption p"><p>Cardiac function surveillance practices by health system</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1"></th>
<th align="left" colspan="1" rowspan="1">Parkland</th>
<th align="left" colspan="1" rowspan="1">UTSW</th>
<th align="left" colspan="1" rowspan="1">Total</th>
<th align="left" colspan="1" rowspan="1"></th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">
<em>n</em> = 93</th>
<th align="left" colspan="1" rowspan="1">
<em>n</em> = 142</th>
<th align="left" colspan="1" rowspan="1">
<em>n</em> = 235</th>
<th align="left" colspan="1" rowspan="1">
<em>p</em>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Number of LVEF assessments, mean (SD)</td>
<td align="left" colspan="1" rowspan="1">4.4 (1.1)</td>
<td align="left" colspan="1" rowspan="1">4.2 (1.3)</td>
<td align="left" colspan="1" rowspan="1">4.3 (1.2)</td>
<td align="left" colspan="1" rowspan="1">0.222</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Baseline LVEF assessment completed</td>
<td align="left" colspan="1" rowspan="1">78 (84%)</td>
<td align="left" colspan="1" rowspan="1">126 (89%)</td>
<td align="left" colspan="1" rowspan="1">204 (87%)</td>
<td align="left" colspan="1" rowspan="1">0.282</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Types of LVEF assessment, (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> MUGA</td>
<td align="left" colspan="1" rowspan="1">34%</td>
<td align="left" colspan="1" rowspan="1">0.17%</td>
<td align="left" colspan="1" rowspan="1">14%</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> cMRI</td>
<td align="left" colspan="1" rowspan="1">0%</td>
<td align="left" colspan="1" rowspan="1">0.17%</td>
<td align="left" colspan="1" rowspan="1">0%</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> TTE</td>
<td align="left" colspan="1" rowspan="1">66%</td>
<td align="left" colspan="1" rowspan="1">99.67%</td>
<td align="left" colspan="1" rowspan="1">86%</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Time between LVEF assessments, days, mean (SD)</td>
<td align="left" colspan="1" rowspan="1">99 (23)</td>
<td align="left" colspan="1" rowspan="1">97 (22)</td>
<td align="left" colspan="1" rowspan="1">98 (22)</td>
<td align="left" colspan="1" rowspan="1">0.549</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Post-trastuzumab LVEF assessment completed</td>
<td align="left" colspan="1" rowspan="1">50 (54%)</td>
<td align="left" colspan="1" rowspan="1">76 (54%)</td>
<td align="left" colspan="1" rowspan="1">136 (54%)</td>
<td align="left" colspan="1" rowspan="1">0.971</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Initial LVEF, mean (SD)</td>
<td align="left" colspan="1" rowspan="1">62 (5.8)</td>
<td align="left" colspan="1" rowspan="1">61 (4.9)</td>
<td align="left" colspan="1" rowspan="1">62 (5.3)</td>
<td align="left" colspan="1" rowspan="1">0.202</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Nadir LVEF, mean (SD)</td>
<td align="left" colspan="1" rowspan="1">56 (4.6)</td>
<td align="left" colspan="1" rowspan="1">56 (5.0)</td>
<td align="left" colspan="1" rowspan="1">56 (4.9)</td>
<td align="left" colspan="1" rowspan="1">0.217</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Change in LVEF (baseline to nadir), mean (SD)</td>
<td align="left" colspan="1" rowspan="1">-5.7 (5.2)</td>
<td align="left" colspan="1" rowspan="1">-5.7 (5.2)</td>
<td align="left" colspan="1" rowspan="1">-5.7 (5.2)</td>
<td align="left" colspan="1" rowspan="1">1.00</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Initial GLS, mean (SD)</td>
<td align="left" colspan="1" rowspan="1">-20 (2.7)</td>
<td align="left" colspan="1" rowspan="1">-19 (2.2)</td>
<td align="left" colspan="1" rowspan="1">-19 (2.5)</td>
<td align="left" colspan="1" rowspan="1">0.0007</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Nadir GLS, mean (SD)</td>
<td align="left" colspan="1" rowspan="1">-18 (2.5)</td>
<td align="left" colspan="1" rowspan="1">-17 (1.8)</td>
<td align="left" colspan="1" rowspan="1">-18 (2.2)</td>
<td align="left" colspan="1" rowspan="1">0.0001</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Change in GLS (baseline to nadir), mean (SD)</td>
<td align="left" colspan="1" rowspan="1">1.4 (1.8)</td>
<td align="left" colspan="1" rowspan="1">1.4 (1.6)</td>
<td align="left" colspan="1" rowspan="1">1.4 (1.7)</td>
<td align="left" colspan="1" rowspan="1">1.00</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><section class="tw xbox font-sm" id="Tab3"><h3 class="obj_head">Table 3.</h3>
<div class="caption p"><p>CTRCD rates by health system</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1"></th>
<th align="left" colspan="1" rowspan="1">Parkland</th>
<th align="left" colspan="1" rowspan="1">UTSW</th>
<th align="left" colspan="1" rowspan="1">Total</th>
<th align="left" colspan="1" rowspan="1"></th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">
<em>n</em> = 93</th>
<th align="left" colspan="1" rowspan="1">
<em>n</em> = 142</th>
<th align="left" colspan="1" rowspan="1">
<em>n</em> = 235</th>
<th align="left" colspan="1" rowspan="1">
<em>p</em>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">CTRCD incidence</td>
<td align="left" colspan="1" rowspan="1">11 (12%)</td>
<td align="left" colspan="1" rowspan="1">27 (19%)</td>
<td align="left" colspan="1" rowspan="1">38 (16%)</td>
<td align="left" colspan="1" rowspan="1">0.143</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CTRCD type*</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">0.425</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Symptomatic</td>
<td align="left" colspan="1" rowspan="1">1 (1.1%)</td>
<td align="left" colspan="1" rowspan="1">0 (0%)</td>
<td align="left" colspan="1" rowspan="1">1 (0.43%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Severe asymptomatic</td>
<td align="left" colspan="1" rowspan="1">0 (0%)</td>
<td align="left" colspan="1" rowspan="1">2 (1.4%)</td>
<td align="left" colspan="1" rowspan="1">2 (0.85%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Moderate asymptomatic</td>
<td align="left" colspan="1" rowspan="1">2 (2.2%)</td>
<td align="left" colspan="1" rowspan="1">8 (5.6%)</td>
<td align="left" colspan="1" rowspan="1">10 (4.3%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Mild asymptomatic</td>
<td align="left" colspan="1" rowspan="1">8 (8.6%)</td>
<td align="left" colspan="1" rowspan="1">17 (12%)</td>
<td align="left" colspan="1" rowspan="1">25 (11%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p28">
<p>*Definitions used for CTRCD:</p>
<p>Symptomatic: Determined by chart review of follow-up notes</p>
<p>Severe asymptomatic: New LVEF reduction to &lt; 40%</p>
<p>Moderate asymptomatic: New LVEF reduction by ≥ 10% points to an LVEF of 40–49% OR new LVEF reduction by &lt; 10% points to an LVEF of 40–49% and new relative decline in GLS by &gt; 15%</p>
<p>Mild asymptomatic: LVEF ≥ 50% and new relative decline in GLS by &gt; 15% from baseline</p>
<p>Abbreviations:</p>
<p>BB = beta blocker. ACEI = angiotensin-converting enzyme inhibitor. ARB = angiotensin receptor blocker. SLGT2i = sodium-glucose cotransporter 2 inhibitor. MRA = mineralocorticoid receptor antagonist. CTRCD = cancer therapy-related cardiac dysfunction. LVEF = left ventricular ejection fraction. GLS = global longitudinal strain</p>
</div></div></section><section class="tw xbox font-sm" id="Tab4"><h3 class="obj_head">Table 4.</h3>
<div class="caption p"><p>Cohort characteristics and cardiac function surveillance practices among those who developed CTRCD by health system</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1"></th>
<th align="left" colspan="1" rowspan="1">Parkland</th>
<th align="left" colspan="1" rowspan="1">UTSW</th>
<th align="left" colspan="1" rowspan="1"></th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">
<em>n</em> = 11</th>
<th align="left" colspan="1" rowspan="1">
<em>n</em> = 27</th>
<th align="left" colspan="1" rowspan="1">
<em>p</em>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Age, years, mean (SD)</td>
<td align="left" colspan="1" rowspan="1">51 (10)</td>
<td align="left" colspan="1" rowspan="1">56 (14)</td>
<td align="left" colspan="1" rowspan="1">0.654</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Race</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> White</td>
<td align="left" colspan="1" rowspan="1">1 (9.1%)</td>
<td align="left" colspan="1" rowspan="1">16 (59%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Black</td>
<td align="left" colspan="1" rowspan="1">1 (9.1%)</td>
<td align="left" colspan="1" rowspan="1">7 (26%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Hispanic</td>
<td align="left" colspan="1" rowspan="1">8 (73%)</td>
<td align="left" colspan="1" rowspan="1">0 (0%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Other</td>
<td align="left" colspan="1" rowspan="1">1 (9.1%)</td>
<td align="left" colspan="1" rowspan="1">4 (15%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Insurance</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Private</td>
<td align="left" colspan="1" rowspan="1">0 (0%)</td>
<td align="left" colspan="1" rowspan="1">17 (63%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Medicare/Medicaid</td>
<td align="left" colspan="1" rowspan="1">4 (36%)</td>
<td align="left" colspan="1" rowspan="1">9 (33%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> No Insurance</td>
<td align="left" colspan="1" rowspan="1">7 (64%)</td>
<td align="left" colspan="1" rowspan="1">0 (0%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">History of dyslipidemia</td>
<td align="left" colspan="1" rowspan="1">9 (82%)</td>
<td align="left" colspan="1" rowspan="1">18 (67%)</td>
<td align="left" colspan="1" rowspan="1">0.452</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">History of diabetes mellitus</td>
<td align="left" colspan="1" rowspan="1">3 (27%)</td>
<td align="left" colspan="1" rowspan="1">6 (22%)</td>
<td align="left" colspan="1" rowspan="1">0.700</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">History of hypertension</td>
<td align="left" colspan="1" rowspan="1">6 (55%)</td>
<td align="left" colspan="1" rowspan="1">13 (48%)</td>
<td align="left" colspan="1" rowspan="1">1.00</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">On prior cardioprotective agents (BB, ACEI/ARB, SLGT2i, MRA)</td>
<td align="left" colspan="1" rowspan="1">3 (27%)</td>
<td align="left" colspan="1" rowspan="1">7 (26%)</td>
<td align="left" colspan="1" rowspan="1">1.00</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Trastuzumab duration, days, mean (SD)</td>
<td align="left" colspan="1" rowspan="1">366 (33)</td>
<td align="left" colspan="1" rowspan="1">350 (115)</td>
<td align="left" colspan="1" rowspan="1">0.651</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Treatment with pertuzumab</td>
<td align="left" colspan="1" rowspan="1">9 (82%)</td>
<td align="left" colspan="1" rowspan="1">21 (78%)</td>
<td align="left" colspan="1" rowspan="1">1.00</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Treatment with anthracycline</td>
<td align="left" colspan="1" rowspan="1">2 (18%)</td>
<td align="left" colspan="1" rowspan="1">5 (19%)</td>
<td align="left" colspan="1" rowspan="1">1.00</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Number of LVEF assessments, mean (SD)</td>
<td align="left" colspan="1" rowspan="1">5.0 (0.89)</td>
<td align="left" colspan="1" rowspan="1">4.6 (1.3)</td>
<td align="left" colspan="1" rowspan="1">0.176</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Baseline LVEF assessment completed</td>
<td align="left" colspan="1" rowspan="1">9 (82%)</td>
<td align="left" colspan="1" rowspan="1">24 (89%)</td>
<td align="left" colspan="1" rowspan="1">0.615</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Time between LVEF assessments, days, mean (SD)</td>
<td align="left" colspan="1" rowspan="1">88 (11)</td>
<td align="left" colspan="1" rowspan="1">94 (29)</td>
<td align="left" colspan="1" rowspan="1">0.489</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Post-trastuzumab LVEF assessment completed</td>
<td align="left" colspan="1" rowspan="1">8 (73%)</td>
<td align="left" colspan="1" rowspan="1">21 (78%)</td>
<td align="left" colspan="1" rowspan="1">0.700</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Initial LVEF, mean (SD)</td>
<td align="left" colspan="1" rowspan="1">62 (5.9)</td>
<td align="left" colspan="1" rowspan="1">61 (5.0)</td>
<td align="left" colspan="1" rowspan="1">0.613</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Nadir LVEF, mean (SD)</td>
<td align="left" colspan="1" rowspan="1">55 (6.1)</td>
<td align="left" colspan="1" rowspan="1">52 (7.7)</td>
<td align="left" colspan="1" rowspan="1">0.167</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Change in LVEF (baseline to nadir), mean (SD)</td>
<td align="left" colspan="1" rowspan="1">-6.8 (6.1)</td>
<td align="left" colspan="1" rowspan="1">-9.5 (6.8)</td>
<td align="left" colspan="1" rowspan="1">0.259</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Final LVEF of 50% or greater at the end of the 13-month follow-up period</td>
<td align="left" colspan="1" rowspan="1">11 (100%)</td>
<td align="left" colspan="1" rowspan="1">23 (85%)</td>
<td align="left" colspan="1" rowspan="1">0.303</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Initial GLS, mean (SD)</td>
<td align="left" colspan="1" rowspan="1">-21 (2.6)</td>
<td align="left" colspan="1" rowspan="1">-19 (3.0)</td>
<td align="left" colspan="1" rowspan="1">0.019</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Nadir GLS, mean (SD)</td>
<td align="left" colspan="1" rowspan="1">-17 (2.9)</td>
<td align="left" colspan="1" rowspan="1">-16 (2.1)</td>
<td align="left" colspan="1" rowspan="1">0.269</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Change in GLS (baseline to nadir), mean (SD)</td>
<td align="left" colspan="1" rowspan="1">4.4 (2.2)</td>
<td align="left" colspan="1" rowspan="1">3.4 (1.7)</td>
<td align="left" colspan="1" rowspan="1">0.197</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p id="Par24">Based on our risk stratification scheme, there were similar proportions of high-risk patients at Parkland and UTSW. However, the risk factors contributing to high-risk classification differed between the two institutions; at Parkland, a greater proportion of high-risk patients were classified as such due to a history of hypertension and diabetes mellitus (20% at Parkland vs. 11% at UTSW, <em>p</em> = 0.0025), whereas at UTSW, advanced age was more commonly the predominant risk factor (15% at UTSW vs. 4.3% at Parkland, <em>p</em> = 0.0253). There were no differences in ZIP code distributions between patients who were and were not identified as high-risk. There were also no differences in ZIP code distributions between patients who did and did not undergo baseline and post-trastuzumab LVEF assessments.</p>
<p id="Par25">Of those 30 high-risk patients at Parkland, only 2 (6.7%) patients were referred to cardio-oncology or cardiology specialists while 39 of the 58 high-risk patients at UTSW (67%) received such referrals. Of the Parkland patients who received referrals, one was referred externally to UTSW’s cardio-oncology clinic while the other was referred to Parkland’s general cardiology clinic. Of all the high-risk patients referred, only one patient at UTSW did not successfully establish care with cardio-oncology or cardiology. Of the entire UTSW cohort, including non-high-risk patients, 81 (57%) patients were referred to cardio-oncology. Of the 81 referrals, 73 (90%) were by breast or general oncology, 4 (4.9%) by surgical oncology, 3 (3.7%) by general or hospital medicine, and 1 (1.2%) by emergency medicine. Table <a href="#Tab5" class="usa-link">5</a> summarizes the referral patterns across the risk groups and health systems.</p>
<section class="tw xbox font-sm" id="Tab5"><h3 class="obj_head">Table 5.</h3>
<div class="caption p"><p>Characteristics of high-risk patients and cardio-oncology referral patterns by health system</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1"></th>
<th align="left" colspan="1" rowspan="1">Parkland</th>
<th align="left" colspan="1" rowspan="1">UTSW</th>
<th align="left" colspan="1" rowspan="1"></th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">
<em>n</em> = 93</th>
<th align="left" colspan="1" rowspan="1">
<em>n</em> = 142</th>
<th align="left" colspan="1" rowspan="1">
<em>p</em>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">High-risk patients*</td>
<td align="left" colspan="1" rowspan="1">30 (32%)</td>
<td align="left" colspan="1" rowspan="1">58 (41%)</td>
<td align="left" colspan="1" rowspan="1">0.215</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> History of heart failure or cardiomyopathy</td>
<td align="left" colspan="1" rowspan="1">1 (1.1%)</td>
<td align="left" colspan="1" rowspan="1">6 (4.2%)</td>
<td align="left" colspan="1" rowspan="1">0.415</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Baseline LVEF 54% or less</td>
<td align="left" colspan="1" rowspan="1">6 (6.5%)</td>
<td align="left" colspan="1" rowspan="1">10 (7.0%)</td>
<td align="left" colspan="1" rowspan="1">0.776</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Age of diagnosis 65 years or older</td>
<td align="left" colspan="1" rowspan="1">4 (4.3%)</td>
<td align="left" colspan="1" rowspan="1">22 (15%)</td>
<td align="left" colspan="1" rowspan="1">0.025</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> History of both hypertension and diabetes mellitus</td>
<td align="left" colspan="1" rowspan="1">19 (20%)</td>
<td align="left" colspan="1" rowspan="1">16 (11%)</td>
<td align="left" colspan="1" rowspan="1">0.003</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Prior anthracycline use</td>
<td align="left" colspan="1" rowspan="1">5 (5.4%)</td>
<td align="left" colspan="1" rowspan="1">16 (11%)</td>
<td align="left" colspan="1" rowspan="1">0.301</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Referred to cardio-oncology/cardiology</td>
<td align="left" colspan="1" rowspan="1">2 (6.7%)</td>
<td align="left" colspan="1" rowspan="1">39 (67%)</td>
<td align="left" colspan="1" rowspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Established with cardio-oncology/cardiology</td>
<td align="left" colspan="1" rowspan="1">2 (6.7%)</td>
<td align="left" colspan="1" rowspan="1">38 (66%)</td>
<td align="left" colspan="1" rowspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Total patients referred**</td>
<td align="left" colspan="1" rowspan="1">2</td>
<td align="left" colspan="1" rowspan="1">81</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Specialists who placed the referral</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Breast or general oncology</td>
<td align="left" colspan="1" rowspan="1">2 (100%)</td>
<td align="left" colspan="1" rowspan="1">73 (90%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Surgical oncology</td>
<td align="left" colspan="1" rowspan="1">0 (0%)</td>
<td align="left" colspan="1" rowspan="1">4 (4.9%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> General or hospital medicine</td>
<td align="left" colspan="1" rowspan="1">0 (0%)</td>
<td align="left" colspan="1" rowspan="1">3 (3.7%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Emergency medicine</td>
<td align="left" colspan="1" rowspan="1">0 (0%)</td>
<td align="left" colspan="1" rowspan="1">1 (1.2%)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p41">
<p>*Defined as having any one of the following characteristics: history of heart failure or cardiomyopathy, baseline LVEF 54% or less, age of diagnosis 65 years or older, history of both hypertension and diabetes mellitus, and having received prior anthracyclines. Definition adapted from the Heart Failure Association—International Cardio-Oncology Society risk stratification scheme</p>
<p>**Including non-high-risk patients</p>
</div></div></section></section><section id="Sec4"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par27">Our study presents a novel characterization and comparison of two populations of patients with breast cancer receiving trastuzumab in a safety-net and tertiary care hospital system and of the cardiac function surveillance patterns in these two unique populations and care settings.</p>
<p id="Par28">When comparing the patient populations from Parkland and UTSW, demographics differed significantly with Parkland having predominantly Hispanic and Black patients and UTSW having predominantly White patients. Most Parkland patients were uninsured while most UTSW patients had private insurance. These differences are expected given the distinct populations served by a safety-net system compared to a tertiary care center. Although the two populations differed in demographic characteristics, they exhibited similar rates of comorbidities (except for Parkland patients having a higher rate of diabetes), number of cardiovascular risk factors (with Parkland patients trending toward a higher proportion with three cardiovascular risk factors, 17% at Parkland vs. 8.5% at UTSW, <em>p</em> = 0.0624), and baseline medication use, suggesting a comparable burden of disease from a cardiovascular perspective. Both populations received a similar mean duration of trastuzumab therapy consistent with the expected 1-year duration of adjuvant trastuzumab for early-stage HER2-positive breast cancer. The Parkland population had significantly higher use of concurrent pertuzumab, which is reflective of the higher rate of node positive/larger tumors in the safety-net patient population. However, this combination with trastuzumab is unlikely to contribute additional cardiotoxicity [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. In contrast, the rate of anthracycline use, which is known to increase cardiotoxic risk, was similar between the two sites, further underscoring the comparable baseline cardiovascular risk profiles across both populations.</p>
<p id="Par29">Parkland and UTSW had similar adherence rates to guideline recommendations for cardiac function surveillance throughout trastuzumab therapy. In both hospital systems, over 80% of patients underwent baseline surveillance of cardiac function, mainly with TTE or MUGA scans when access to TTE was delayed, and the mean time between interval assessments was approximately 3 months. Our observed adherence rates to surveillance recommendations exceed those reported in a prior study, which found that only 36% of patients underwent baseline cardiac assessment followed by subsequent assessments every 4 months [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. This reflects the fact that Parkland and UTSW are part of an academic medical center with physicians at both locations belonging to the same academic practice group. However, overall, there is a paucity of research evaluating adherence to recommended surveillance guidelines. While rates of baseline cardiac function assessment and interval assessment throughout trastuzumab therapy was adequate in our cohort (&gt; 80% rate of baseline assessment; 3-month mean interval between assessments), only about half of patients at both Parkland and UTSW completed post-treatment assessments following trastuzumab completion. This lack of follow-up is likely due to a combination of patient, provider, and institutional factors and represents a significant gap in care as the risk of developing CTRCD persists well after trastuzumab completion. Additional research is needed to identify barriers to obtaining follow-up cardiac surveillance post-chemotherapy and improve adherence to this guideline recommendation.</p>
<p id="Par30">The primary difference in surveillance practices between the two hospital systems was the usage of MUGA scans. Parkland physicians often use MUGA when access to TTE is delayed. Historically, MUGA scans have been used to monitor cardiac function in patients treated with anthracyclines. As TTE and other imaging modalities have become more readily available, surveillance with MUGA scans has fallen out of favor. Although the risk is minimal, exposure to radiation from MUGA scans should be considered when used as a surveillance modality [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. Given that lower-income, indigent patients at Parkland were more likely to undergo a MUGA scan, concerns for equity are raised as this population was more likely to be exposed to higher levels of radiation toxicity. Additionally, many patients alternated between MUGA scans and TTE, which can limit retrospective comparison due to inter-modality variation in measurements of cardiac function [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>].</p>
<p id="Par31">Notably, the presence of a cardio-oncology service at UTSW did not impact the surveillance practices between the two hospital systems, likely because the medical oncology providers are the same at both locations and are frequently the providers who order the imaging studies, especially at Parkland where few oncology patients were connected with cardiology providers. Given the short follow-up period of our study, we are unable to assess the impact of the cardio-oncology service on long-term outcomes related to cardiotoxicity surveillance and the development of CTRCD. While our findings suggests that a safety-net hospital system may be able to achieve cardiotoxicity surveillance practices and short-term cardiovascular outcomes similar to those of a tertiary care center, further research with extended follow-up is needed to evaluate the impact of a dedicated cardio-oncology program on long-term cardiovascular outcomes.</p>
<p id="Par32">The rates of CTRCD found in our cohort (12% at Parkland and 19% at UTSW) are similar to each other and to rates found in prior studies [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>, <a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>, <a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>], although our findings fall on the higher end of the reported range. This may be due to our inclusion of GLS changes in the definition of CTRCD, unlike other studies that relied only on LVEF changes or symptoms of clinical heart failure to define CTRCD. The inflation of CTRCD rates due to inclusion of GLS criteria is more prominent for UTSW compared to Parkland due to the proportionally higher utilization of TTE compared to MUGA, which does not measure GLS. Supporting the comparable CTRCD rates between the two institutions are the similar inter-site prevalences of known CTRCD risk factors, including hypertension and dyslipidemia. Baseline and nadir LVEF and GLS were similar between patients at Parkland and UTSW, with most patients recovering their LVEF and GLS following trastuzumab completion. Overall, our findings suggest that with consistent cardiac surveillance, the incidence and management of CTRCD are similar across different healthcare settings in our study. Furthermore, both sites in our cohort conducted surveillance at appropriate intervals, and most patients diagnosed with CTRCD ultimately recovered their cardiac function.</p>
<p id="Par33">Nevertheless, our results still show that there is marked underutilization of cardio-oncology and cardiology services in the care of patients with breast cancer receiving cardiotoxic therapies. Prior studies have demonstrated that a variety of reasons, such as institutional restrictions or excessive patient travel time, have hindered primary care and oncology referrals for patients with cancer to receive further specialized care [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. At UTSW, less than 70% of patients identified as high-risk for CTRCD—based on a risk-stratification approach aligned with that of current guidelines—were connected to cardio-oncology. At Parkland, fewer than 10% of high-risk patients were referred either externally to cardio-oncology or internally to cardiology. Notably, only one patient at Parkland was externally referred to cardio-oncology at UTSW despite the proximity of Parkland and UTSW, likely reflecting disparities in insurance coverage and limited capacity for cross-system referrals. While Parkland’s current practice may not prioritize cardiology referral in the absence of overt CTRCD, this represents a potential area for intervention. Establishing a dedicated cardio-oncology service could facilitate earlier and more frequent referrals; however, such efforts may be constrained by the resource limitations commonly faced by safety-net hospital systems.</p>
<p id="Par34">In regard to improving the overall care of patients receiving cardiotoxic medications, there are several opportunities for our hospital systems as well as other institutions to deliver higher quality care. For instance, faculty within Parkland are developing patient education resources to emphasize and promote patient awareness of cardiovascular health among those undergoing oncologic treatment as well as breast cancer survivors. These fliers will serve as a reminder to both the patient and provider to discuss management of cardiovascular risk factors during patient encounters. At UTSW, cardio-oncology faculty have previously conducted patient-centric seminars to highlight the importance of cardiovascular health in oncologic patients and the important role that the cardio-oncology department plays in supporting this aspect of their care. Continuing these seminars on a regular basis would further promote patient awareness and encourage active engagement in managing their cardiovascular health. Additionally, the integration of nurse navigators into oncology and cardio-oncology clinics is another area for improvement, especially at Parkland and UTSW where such roles are not currently in place. In institutions where nurse navigators are utilized, their responsibilities may include screening patients who have been referred to cardio-oncology, collecting relevant oncologic history to streamline upcoming visits, and reviewing oncology service patient panels to identify high-risk individuals who have not yet been referred and recommend appropriate referrals. Furthermore, in institutions where there are no dedicated cardio-oncology departments, it may be helpful for future studies to explore the possibility of scheduling echocardiograms upfront. This may help promote improved surveillance rates and allow patients to communicate to their physicians sooner if they are unable to attend a scheduled imaging appointment and facilitate efficient re-scheduling.</p>
<p id="Par35">Our study also highlights that the majority of referrals were placed by oncologists, with a small portion of referrals placed by breast oncology surgeons and internal medicine physicians. This observation illustrates the significant burden placed on oncologists to refer patients to cardio-oncology to help guide cardiovascular risk management. However, considering that cancer care is multidisciplinary in nature, our overall healthcare system may benefit from sharing this responsibility with primary care physicians, hospitalists, and other providers who may participate in patient care at various timepoints [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>, <a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. Prior studies have also highlighted the important role primary care providers play in cardio-oncology by engaging with patients throughout all phases of cancer treatment [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]. By increasing the visibility of cardio-oncology within other departments, this may improve referral rates and promote surveillance for CTRCD within any given hospital system [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. In future studies, it may also be worthwhile to analyze whether development of risk calculators for patients receiving cardiotoxic medications and best practice advisory pop-ups in the electronic health records may help with ease of appropriate referrals.</p>
<p id="Par36">Although the cardiotoxic effects of various chemotherapies are well-known within oncology, physicians often face time constraints during clinic visits, which limits their ability to address all aspects of a patient’s care [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>, <a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>], including cardiovascular risk and surveillance. As the cardiotoxic effects of breast cancer treatments are not immediate, physicians may unintentionally address more urgent topics when building rapport with their patients. Patients with cancer also may be inundated with information and unable to fully comprehend all aspects of their treatment plans [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>, <a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. This may be further exacerbated when serving diverse patient populations requiring the use of translators [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. Collectively, these barriers may hinder timely access to cardiac surveillance for patients with cancer. Further research is needed to understand physician attitudes towards cardiotoxicity surveillance and cardiovascular health discussions with patients when establishing cancer care.</p>
<p id="Par37">Our study has several limitations, especially considering its retrospective nature and inability to draw causal relationships. It was also challenging to ascertain whether chemotherapy was discontinued in response to changes in LVEF or GLS, a potential balancing measure that could indicate harm associated with excessive surveillance. This was particularly true for patients at UTSW, many of whom received portions of their cancer care across multiple institutions, resulting in incomplete documentation of their chemotherapy course. Our study also did not assess physician perspectives or patient attitudes regarding the importance of cardiac surveillance in cancer care. As our study relies on information documented on patient records, there may be conversations regarding cardiac surveillance, referrals to further specialists, or challenges with frequent cardiac surveillance that are not reflected in our study.</p></section><section id="Sec5"><h2 class="pmc_sec_title">Conclusions</h2>
<p id="Par38">Our study is the first to characterize patient demographics, cardiac function surveillance patterns, short-term CTRCD-related outcomes, and utilization rates of cardio-oncology specialists in patients with HER2-positive breast cancer receiving trastuzumab therapy across two unique hospital systems. Our results demonstrate relatively high rates of cardiac surveillance at both institutions, with the exception of post-chemotherapy cardiac surveillance. Resource limitations in the safety-net setting, however, contribute to the use of MUGA as an alternative to TTE and significant underutilization of specialized care for cardiac care/risk mitigation compared to a tertiary care center with a cardio-oncology program. Our results also underscore the need for a more integrated, multidisciplinary approach to care, particularly in improving cardiology referral rates and ensuring appropriate cardiac surveillance for patients with breast cancer who are receiving cardiotoxic chemotherapy and are high-risk for CTRCD.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>None.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>ACEI</dt>
<dd><p id="Par42">Angiotensin-converting enzyme inhibitor</p></dd>
<dt>ARB</dt>
<dd><p id="Par43">Angiotensin receptor blocker</p></dd>
<dt>BB</dt>
<dd><p id="Par44">Beta blocker</p></dd>
<dt>CTRCD</dt>
<dd><p id="Par45">Cancer therapy-related cardiac dysfunction</p></dd>
<dt>ESC</dt>
<dd><p id="Par46">European Society of Cardiology</p></dd>
<dt>GLS</dt>
<dd><p id="Par47">Global longitudinal strain</p></dd>
<dt>HER2</dt>
<dd><p id="Par48">Human epidermal growth factor receptor-2</p></dd>
<dt>HFA-ICOS</dt>
<dd><p id="Par49">Heart Failure Association-International Cardio-Oncology Society</p></dd>
<dt>LVEF</dt>
<dd><p id="Par50">Left ventricular ejection fraction</p></dd>
<dt>MRA</dt>
<dd><p id="Par51">Mineralocorticoid receptor antagonist</p></dd>
<dt>MRI</dt>
<dd><p id="Par52">Magnetic resonance imaging</p></dd>
<dt>MUGA</dt>
<dd><p id="Par53">Multigated acquisition</p></dd>
<dt>SLGT2i</dt>
<dd><p id="Par54">Sodium-glucose cotransporter 2 inhibitor</p></dd>
<dt>TTE</dt>
<dd><p id="Par55">Transthoracic echocardiography</p></dd>
<dt>UTSW</dt>
<dd><p id="Par56">University of Texas Southwestern</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>All authors contributed to the design and implementation of the research and editing the manuscript. LH, PM, and MS developed methodology, performed chart review, analyzed data, and wrote the original draft of the manuscript. LH prepared all tables and figures and prepared the final manuscript. NS and AC oversaw data analysis and reviewed and edited the manuscript. All authors proofread and approved the final manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>There were no sources of funding used to conduct this study.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par39">All patients included in this study consented to their inclusion in the study. The study protocol was approved by the local Institutional Review Board.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par40">Not applicable.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par41">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div>
<div class="fn p" id="fn2"><p>Le Huang, Pratyusha Manthena and Malcolm Su contributed equally to this work.</p></div>
<div class="fn p" id="fn3"><p>Alvin Chandra and Navid Sadeghi contributed equally to this work.</p></div>
</div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Elshazly AM, Gewirtz DA. An overview of resistance to human epidermal growth factor receptor 2 (Her2) targeted therapies in breast cancer. Cancer Drug Resist. 2022;5(2):472–86.
</cite> [<a href="https://doi.org/10.20517/cdr.2022.09" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9255238/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35800378/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Elshazly%20AM,%20Gewirtz%20DA.%20An%20overview%20of%20resistance%20to%20human%20epidermal%20growth%20factor%20receptor%202%20(Her2)%20targeted%20therapies%20in%20breast%20cancer.%20Cancer%20Drug%20Resist.%202022;5(2):472%E2%80%9386." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Iqbal N, Iqbal N. Human epidermal growth factor receptor 2 (HER2) in cancers: overexpression and therapeutic implications. Mol Biology Int. 2014;2014(1):1–9.</cite> [<a href="https://doi.org/10.1155/2014/852748" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4170925/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25276427/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Iqbal%20N,%20Iqbal%20N.%20Human%20epidermal%20growth%20factor%20receptor%202%20(HER2)%20in%20cancers:%20overexpression%20and%20therapeutic%20implications.%20Mol%20Biology%20Int.%202014;2014(1):1%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Lau KH, Tan AM, Shi Y. New and emerging targeted therapies for advanced breast cancer. Int J Mol Sci. 2022;23(4):2288.
</cite> [<a href="https://doi.org/10.3390/ijms23042288" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8874375/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35216405/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lau%20KH,%20Tan%20AM,%20Shi%20Y.%20New%20and%20emerging%20targeted%20therapies%20for%20advanced%20breast%20cancer.%20Int%20J%20Mol%20Sci.%202022;23(4):2288." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Gullo G, Walsh N, Fennelly D, Bose R, Walshe J, Tryfonopoulos D, et al. Impact of timing of trastuzumab initiation on long-term outcome of patients with early-stage HER2-positive breast cancer: the one thousand HER2 patients project. Br J Cancer. 2018;119(3):374–80.
</cite> [<a href="https://doi.org/10.1038/s41416-018-0114-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6070916/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29773838/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gullo%20G,%20Walsh%20N,%20Fennelly%20D,%20Bose%20R,%20Walshe%20J,%20Tryfonopoulos%20D,%20et%20al.%20Impact%20of%20timing%20of%20trastuzumab%20initiation%20on%20long-term%20outcome%20of%20patients%20with%20early-stage%20HER2-positive%20breast%20cancer:%20the%20one%20thousand%20HER2%20patients%20project.%20Br%20J%20Cancer.%202018;119(3):374%E2%80%9380." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Goutsouliak K, Veeraraghavan J, Sethunath V, De Angelis C, Osborne CK, Rimawi MF, et al. Towards personalized treatment for early stage HER2-positive breast cancer. Nat Reviews Clin Oncol. 2019;17(4):233–50.</cite> [<a href="https://doi.org/10.1038/s41571-019-0299-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8023395/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31836877/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Goutsouliak%20K,%20Veeraraghavan%20J,%20Sethunath%20V,%20De%20Angelis%20C,%20Osborne%20CK,%20Rimawi%20MF,%20et%20al.%20Towards%20personalized%20treatment%20for%20early%20stage%20HER2-positive%20breast%20cancer.%20Nat%20Reviews%20Clin%20Oncol.%202019;17(4):233%E2%80%9350." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Theofilis P, Vlachakis PK, Oikonomou E, Drakopoulou M, Karakasis P, Apostolos A, et al. Cancer Therapy-Related cardiac dysfunction: A review of current trends in epidemiology, diagnosis, and treatment. Biomedicines. 2024 Spring;12(12):2914.</cite> [<a href="https://doi.org/10.3390/biomedicines12122914" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11673750/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39767820/" class="usa-link">PubMed</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Contaldi C, D’Aniello C, Panico D, Zito A, Paolo Calabrò, Lorenzo ED et al. Cancer-Therapy-Related Cardiac Dysfunction: Latest Advances in Prevention and Treatment. Life. 2025 Mar 15 [cited 2025 Mar 24];15(3):471–1.</cite> [<a href="https://doi.org/10.3390/life15030471" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11944213/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40141815/" class="usa-link">PubMed</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J et al. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European hematology association (EHA), the European society for therapeutic radiology and oncology (ESTRO) and the international Cardio-Oncology society (IC-OS). Eur Heart J. 2022;43(41).</cite> [<a href="https://doi.org/10.1093/eurheartj/ehac244" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36017568/" class="usa-link">PubMed</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Bouwer NI, Jager A, Liesting C, Kofflard MJM, Brugts JJ, Kitzen JJEM, et al. Cardiac monitoring in HER2-positive patients on trastuzumab treatment: A review and implications for clinical practice. Breast: Official J Eur Soc Mastology. 2020;52:33–44.</cite> [<a href="https://doi.org/10.1016/j.breast.2020.04.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7375662/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32361151/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bouwer%20NI,%20Jager%20A,%20Liesting%20C,%20Kofflard%20MJM,%20Brugts%20JJ,%20Kitzen%20JJEM,%20et%20al.%20Cardiac%20monitoring%20in%20HER2-positive%20patients%20on%20trastuzumab%20treatment:%20A%20review%20and%20implications%20for%20clinical%20practice.%20Breast:%20Official%20J%20Eur%20Soc%20Mastology.%202020;52:33%E2%80%9344." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N, et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American society of clinical oncology clinical practice guideline. J Clin Oncology: Official J Am Soc Clin Oncol. 2017;35(8):893–911.</cite> [<a href="https://doi.org/10.1200/JCO.2016.70.5400" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27918725/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Armenian%20SH,%20Lacchetti%20C,%20Barac%20A,%20Carver%20J,%20Constine%20LS,%20Denduluri%20N,%20et%20al.%20Prevention%20and%20monitoring%20of%20cardiac%20dysfunction%20in%20survivors%20of%20adult%20cancers:%20American%20society%20of%20clinical%20oncology%20clinical%20practice%20guideline.%20J%20Clin%20Oncology:%20Official%20J%20Am%20Soc%20Clin%20Oncol.%202017;35(8):893%E2%80%93911." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>FDA.14.1.3 Final Labeling Text Highlights Of Prescribing Information. Available from: <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/103792s5250lbl.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/103792s5250lbl.pdf</a></cite>
</li>
<li id="CR12">
<span class="label">12.</span><cite>Henry ML, Niu J, Zhang N, Giordano SH, Chavez-MacGregor M. Cardiotoxicity and cardiac monitoring among Chemotherapy-Treated breast cancer patients. JACC: Cardiovasc Imaging. 2018;11(8):1084–93.
</cite> [<a href="https://doi.org/10.1016/j.jcmg.2018.06.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6149535/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30092967/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Henry%20ML,%20Niu%20J,%20Zhang%20N,%20Giordano%20SH,%20Chavez-MacGregor%20M.%20Cardiotoxicity%20and%20cardiac%20monitoring%20among%20Chemotherapy-Treated%20breast%20cancer%20patients.%20JACC:%20Cardiovasc%20Imaging.%202018;11(8):1084%E2%80%9393." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Litvak A, Batukbhai B, Russell SD, Tsai HL, Rosner GL, Jeter SC, et al. Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer. Cancer. 2018;124(9):1904–11.
</cite> [<a href="https://doi.org/10.1002/cncr.31260" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5910274/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29381193/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Litvak%20A,%20Batukbhai%20B,%20Russell%20SD,%20Tsai%20HL,%20Rosner%20GL,%20Jeter%20SC,%20et%20al.%20Racial%20disparities%20in%20the%20rate%20of%20cardiotoxicity%20of%20HER2-targeted%20therapies%20among%20women%20with%20early%20breast%20cancer.%20Cancer.%202018;124(9):1904%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Yosef Manla, Franco FX, Sadler D. Program Building in Cardio-oncology: bridging existing care gaps to improve cardiovascular and cancer outcomes. Curr Treat Options Cardiovasc Med. 2024;26(3):47–67.</cite> [<a href="https://scholar.google.com/scholar_lookup?Yosef%20Manla,%20Franco%20FX,%20Sadler%20D.%20Program%20Building%20in%20Cardio-oncology:%20bridging%20existing%20care%20gaps%20to%20improve%20cardiovascular%20and%20cancer%20outcomes.%20Curr%20Treat%20Options%20Cardiovasc%20Med.%202024;26(3):47%E2%80%9367." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Ramachandran KM, Tsokos CP. Mathematical statistics with applications in R. 2020.</cite>
</li>
<li id="CR16">
<span class="label">16.</span><cite>Zhang L, Wang Y, Meng W, Zhao W, Tong Z. Cardiac safety analysis of anti-HER2-targeted therapy in early breast cancer. Sci Rep. 2022;12(1).</cite> [<a href="https://doi.org/10.1038/s41598-022-18342-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9395410/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35995984/" class="usa-link">PubMed</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Chavez-MacGregor M, Niu J, Zhang N, Elting LS, Smith BD, Banchs J, et al. Cardiac monitoring during adjuvant Trastuzumab-Based chemotherapy among older patients with breast cancer. J Clin Oncol. 2015;33(19):2176–83.
</cite> [<a href="https://doi.org/10.1200/JCO.2014.58.9465" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4979214/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25964256/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chavez-MacGregor%20M,%20Niu%20J,%20Zhang%20N,%20Elting%20LS,%20Smith%20BD,%20Banchs%20J,%20et%20al.%20Cardiac%20monitoring%20during%20adjuvant%20Trastuzumab-Based%20chemotherapy%20among%20older%20patients%20with%20breast%20cancer.%20J%20Clin%20Oncol.%202015;33(19):2176%E2%80%9383." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Addison D, Neilan TG, Barac A, Scherrer-Crosbie M, Okwuosa TM, Plana JC, et al. Cardiovascular imaging in contemporary Cardio-Oncology: A scientific statement from the American heart association. Circulation. 2023;148(16):1271–86.
</cite> [<a href="https://doi.org/10.1161/CIR.0000000000001174" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37732422/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Addison%20D,%20Neilan%20TG,%20Barac%20A,%20Scherrer-Crosbie%20M,%20Okwuosa%20TM,%20Plana%20JC,%20et%20al.%20Cardiovascular%20imaging%20in%20contemporary%20Cardio-Oncology:%20A%20scientific%20statement%20from%20the%20American%20heart%20association.%20Circulation.%202023;148(16):1271%E2%80%9386." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Nolan MT, Pathan F, Nott L, Black A, Pointon O, Marwick TH. Comparison of echocardiography and Multi-Planar gated acquisition scans for predicting Cancer-Treatment-Related cardiovascular dysfunction. Heart Lung Circulation. 2024;33(5):693–703.
</cite> [<a href="https://doi.org/10.1016/j.hlc.2024.03.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38692983/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nolan%20MT,%20Pathan%20F,%20Nott%20L,%20Black%20A,%20Pointon%20O,%20Marwick%20TH.%20Comparison%20of%20echocardiography%20and%20Multi-Planar%20gated%20acquisition%20scans%20for%20predicting%20Cancer-Treatment-Related%20cardiovascular%20dysfunction.%20Heart%20Lung%20Circulation.%202024;33(5):693%E2%80%93703." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, et al. Adjuvant trastuzumab in HER2-Positive breast cancer. N Engl J Med. 2011;365(14):1273–83.
</cite> [<a href="https://doi.org/10.1056/NEJMoa0910383" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3268553/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21991949/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Slamon%20D,%20Eiermann%20W,%20Robert%20N,%20Pienkowski%20T,%20Martin%20M,%20Press%20M,%20et%20al.%20Adjuvant%20trastuzumab%20in%20HER2-Positive%20breast%20cancer.%20N%20Engl%20J%20Med.%202011;365(14):1273%E2%80%9383." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, et al. Trastuzumab after adjuvant chemotherapy in HER2-Positive breast cancer. N Engl J Med. 2005;353(16):1659–72.
</cite> [<a href="https://doi.org/10.1056/NEJMoa052306" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16236737/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Piccart-Gebhart%20MJ,%20Procter%20M,%20Leyland-Jones%20B,%20Goldhirsch%20A,%20Untch%20M,%20Smith%20I,%20et%20al.%20Trastuzumab%20after%20adjuvant%20chemotherapy%20in%20HER2-Positive%20breast%20cancer.%20N%20Engl%20J%20Med.%202005;353(16):1659%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>de Azambuja E, Ponde N, Procter M, Rastogi P, Cecchini RS, Lambertini M, et al. A pooled analysis of the cardiac events in the trastuzumab adjuvant trials. Breast Cancer Res Treat. 2019;179(1):161–71.
</cite> [<a href="https://doi.org/10.1007/s10549-019-05453-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6989393/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31605311/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?de%20Azambuja%20E,%20Ponde%20N,%20Procter%20M,%20Rastogi%20P,%20Cecchini%20RS,%20Lambertini%20M,%20et%20al.%20A%20pooled%20analysis%20of%20the%20cardiac%20events%20in%20the%20trastuzumab%20adjuvant%20trials.%20Breast%20Cancer%20Res%20Treat.%202019;179(1):161%E2%80%9371." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Kwon DH, Tisnado DM, Keating NL, Klabunde CN, Adams JL, Rastegar A, et al. Physician-reported barriers to referring cancer patients to specialists: prevalence, factors, and association with career satisfaction. Cancer. 2014;121(1):113–22.
</cite> [<a href="https://doi.org/10.1002/cncr.29019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4270815/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25196776/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kwon%20DH,%20Tisnado%20DM,%20Keating%20NL,%20Klabunde%20CN,%20Adams%20JL,%20Rastegar%20A,%20et%20al.%20Physician-reported%20barriers%20to%20referring%20cancer%20patients%20to%20specialists:%20prevalence,%20factors,%20and%20association%20with%20career%20satisfaction.%20Cancer.%202014;121(1):113%E2%80%9322." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Walsh J, Harrison JD, Young JM, Butow PN, Solomon MJ, Masya L. What are the current barriers to effective cancer care coordination? A qualitative study. BMC Health Serv Res. 2010;10(1).</cite> [<a href="https://doi.org/10.1186/1472-6963-10-132" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2891740/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20482884/" class="usa-link">PubMed</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Lawrence RA, McLoone JK, Wakefield CE, Cohn RJ. Primary care physicians’ perspectives of their role in cancer care: A systematic review. J Gen Intern Med. 2016;31(10):1222–36.
</cite> [<a href="https://doi.org/10.1007/s11606-016-3746-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5023605/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27220499/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lawrence%20RA,%20McLoone%20JK,%20Wakefield%20CE,%20Cohn%20RJ.%20Primary%20care%20physicians%E2%80%99%20perspectives%20of%20their%20role%20in%20cancer%20care:%20A%20systematic%20review.%20J%20Gen%20Intern%20Med.%202016;31(10):1222%E2%80%9336." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Cehic DA, Sverdlov AL, Koczwara B, Emery J. Doan, elysia Thornton-Benko. The importance of primary care in Cardio-Oncology. Curr Treat Options Oncol. 2021;22(12).</cite> [<a href="https://doi.org/10.1007/s11864-021-00908-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34674055/" class="usa-link">PubMed</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Lancellotti P, Suter TM, López-Fernández T, Galderisi M, Lyon AR, Van der Meer P, et al. Cardio-Oncology services: rationale, organization, and implementation. Eur Heart J. 2018;40(22):1756–63.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehy453" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30085070/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lancellotti%20P,%20Suter%20TM,%20L%C3%B3pez-Fern%C3%A1ndez%20T,%20Galderisi%20M,%20Lyon%20AR,%20Van%20der%20Meer%20P,%20et%20al.%20Cardio-Oncology%20services:%20rationale,%20organization,%20and%20implementation.%20Eur%20Heart%20J.%202018;40(22):1756%E2%80%9363." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Aiello Bowles EJ, Tuzzio L, Wiese CJ, Kirlin B, Greene SM, Clauser SB, et al. Understanding high-quality cancer care. Cancer. 2008;112(4):934–42.
</cite> [<a href="https://doi.org/10.1002/cncr.23250" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18181099/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Aiello%20Bowles%20EJ,%20Tuzzio%20L,%20Wiese%20CJ,%20Kirlin%20B,%20Greene%20SM,%20Clauser%20SB,%20et%20al.%20Understanding%20high-quality%20cancer%20care.%20Cancer.%202008;112(4):934%E2%80%9342." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Fitch MI, Coronado AC, Schippke JC, Chadder J, Green E. Exploring the perspectives of patients about their care experience: identifying what patients perceive are important qualities in cancer care. Support Care Cancer. 2019;28(5):2299–309.
</cite> [<a href="https://doi.org/10.1007/s00520-019-05057-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31478165/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fitch%20MI,%20Coronado%20AC,%20Schippke%20JC,%20Chadder%20J,%20Green%20E.%20Exploring%20the%20perspectives%20of%20patients%20about%20their%20care%20experience:%20identifying%20what%20patients%20perceive%20are%20important%20qualities%20in%20cancer%20care.%20Support%20Care%20Cancer.%202019;28(5):2299%E2%80%93309." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Thorne S, Oliffe JL, Stajduhar KI, Oglov V, Kim-Sing C, Hislop TG. Poor communication in cancer care: patient perspectives on what it is and what to do about it. Cancer Nurs. 2013;36(6):445–53.
</cite> [<a href="https://doi.org/10.1097/NCC.0b013e31827eeda4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23348667/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Thorne%20S,%20Oliffe%20JL,%20Stajduhar%20KI,%20Oglov%20V,%20Kim-Sing%20C,%20Hislop%20TG.%20Poor%20communication%20in%20cancer%20care:%20patient%20perspectives%20on%20what%20it%20is%20and%20what%20to%20do%20about%20it.%20Cancer%20Nurs.%202013;36(6):445%E2%80%9353." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>van Rosse F, de Bruijne M, Suurmond J, Essink-Bot ML, Wagner C. Language barriers and patient safety risks in hospital care. A mixed methods study. Int J Nurs Stud. 2016;54(1):45–53.
</cite> [<a href="https://doi.org/10.1016/j.ijnurstu.2015.03.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25840899/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?van%20Rosse%20F,%20de%20Bruijne%20M,%20Suurmond%20J,%20Essink-Bot%20ML,%20Wagner%20C.%20Language%20barriers%20and%20patient%20safety%20risks%20in%20hospital%20care.%20A%20mixed%20methods%20study.%20Int%20J%20Nurs%20Stud.%202016;54(1):45%E2%80%9353." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Cardio-oncology are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s40959-025-00376-9"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/40959_2025_Article_376.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.2 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12369133/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12369133/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12369133%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369133/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12369133/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12369133/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40842038/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12369133/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40842038/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12369133/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12369133/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="BJYFnwzaMH2aUdOhW0P5txsNrO0dta4HOtaoGIhVa56hhhd9fGYSCpQuPcFD2W3J">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
